These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 66370)

  • 1. [Determination of fibrin-fibrinogen degradation products in the blood serum by an immunological method].
    Andreenko GV; Liutova LB
    Lab Delo; 1976; (4):206-8. PubMed ID: 66370
    [No Abstract]   [Full Text] [Related]  

  • 2. [An immunonephelometric micromethod of determining the levels of fibrin-fibrinogen degradation products].
    Ivanov EP; Tsvirko DG
    Lab Delo; 1989; (10):12-5. PubMed ID: 2481061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methods of determination of fibrin fibrinogen degradation products (review of the literature)].
    Guseínov ChS; Prozorovskaia NN; Mikhaĭlova ND; Gorelova AM; Lagutina NIa
    Lab Delo; 1978; (5):259-66. PubMed ID: 79007
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of the fibrinogen/fibrin antigen content in the blood plasma and serum by radial immunodiffusion].
    Iakunin GA; Smolianitskiĭ AIa; Kurguzova OP; Grabskiĭ MA
    Lab Delo; 1982; (7):408-10. PubMed ID: 6181303
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative determination of fibrinogen and fibrin degradation products by means of immunodiffusion].
    Paradeeva IK; Zhukova IV
    Lab Delo; 1979; (10):590-2. PubMed ID: 94124
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
    Dyr JE; Cajthamlová H; Suttnar J
    Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Gamma'-dimer antibody and its specificity against fibrinogen, FR-a and carboxymethylated chains from fibrinogen and cross-linked fibrin.
    Clausen NT; Gormsen J
    Thromb Diath Haemorrh; 1975 Sep; 34(1):326. PubMed ID: 1188740
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinogen and fibrin degradation products: their differentiation.
    Edgington TS
    Thromb Diath Haemorrh; 1975 Dec; 34(3):671-6. PubMed ID: 54944
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
    Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
    Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinogen and fibrin degradation products].
    Fujimaki M; Ikematsu S; Kato M
    Rinsho Byori; 1973 Jan; 21(1):31-6. PubMed ID: 4267650
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quantitative immunoenzyme method for determining fibrin-fibrinogen degradation products in the blood].
    Ermolin GA; Liusov VA; Panchenko EP
    Lab Delo; 1984; (1):11-5. PubMed ID: 6199554
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of fibrinogen/fibrin degradation products (F/F DP)].
    Alakhverdian R
    Vutr Boles; 1979; 18(3):160-7. PubMed ID: 89851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative determination of D and E fibrinogen fragments using electroimmunodiffusion].
    Ferrari G; Fabucci C
    Boll Ist Sieroter Milan; 1976 Jul; 55(3):221-4. PubMed ID: 828057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid turbidimetric determination of fibrinogen degradation products (FDP).
    Verbruggen HW; Wessels JM
    Thromb Haemost; 1978 Feb; 39(1):12-21. PubMed ID: 580487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diazophenylthio-ether-IgG probe for analysing fibrin- and fibrinogen-related antigens.
    Kruskal JB; Maeder DL; Purves LR; Franks JJ; Kirsch RE
    S Afr Med J; 1987 Feb; 71(4):211-7. PubMed ID: 3824087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
    Brenner B; Francis CW; Marder VJ
    J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test)].
    Vorlová Z; Dyr IE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):967-70. PubMed ID: 94893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities of using immunoenzyme test systems for determining levels of myoglobin, fibrinogen, fibrin-fibrinogen degradation products and fibronectin in the diagnosis of somatic diseases].
    Ermolin GA; Shelepova TM; Dikov MM; Osmanov SK; Voloshchuk OM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):33-7. PubMed ID: 3300700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain.
    Plow EF; Edgington TS
    J Immunol; 1986 Sep; 137(6):1910-5. PubMed ID: 2943807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.